RNS Number : 3105R
3i Group PLC
05 June 2024
 

Market Abuse Regulation

 

MAR Article 19

 

On 5 June 2024, 3i Group plc (the "Company") was notified of the following.  

 

On 4 June 2024 the persons discharging material responsibilities ("PDMRs") named in the table below acquired for nil cost ordinary shares of 73 19/22p each (ISIN: GB00B1YW4409) in the Company ("Shares") on the release of share awards under the 3i Special Share Award Plan. On that date the Shares shown in the column headed "Shares acquired" ceased to be subject to restrictions under the Plan. The Shares (if any) shown in the column headed "Shares sold" were sold on the same date at a price of £29.312904 per share.

 

PDMR

Shares acquired

Shares sold

S Moseley

88,566

41,689

B Sottomayor

88,566

88,566

 

On 4 June 2024 share awards under 3i Group Discretionary Share Plan (the "Plan") held by the persons discharging managerial responsibilities ("PDMRs") named in the table below vested.  On that date the Shares shown in the column headed "Shares acquired" ceased to be subject to restrictions under the Plan.  The Shares (if any) shown in the column headed "Shares sold" were sold on the same date at a price of £29.312904 per share.

 

PDMR

Shares acquired

Shares sold

K J Dunn

15,659

7,378

J H Halai

7,339

3,460

J Hatchley

10,912

5,143

J Marie

6,920

3,263

 

The place of these transactions was the London Stock Exchange.

 

Ends 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPUUUQUPCGMA